Multiparametric Heart Failure Evaluation in Internal Cardioverter Defibrillators (ICD) Patients

Multiparametric Evaluation of Heart Failure in Device-implanted Patients.

The Boston Scientific Energen family is capable of measuring the respiratory rate trend (RRT) on a daily basis and transmission of data via the Remote Monitoring technology. This may result in early detection of imminent decompensation at a presymptomatic stage. The study will assess the respiratory trends correlation with clinically relevant heart failure events.

Inclusion Criteria:

• Patient eligible for 1-, 2- or 3-chamber ICD implantation according to current guidelines or patient already implanted within the past 45 days with a Energen device or successor
• Able to provide written informed consent

Exclusion Criteria:

• Life expectancy <12 months
• Anticipated non-compliance with the follow-up scheme
• Moderate to severe Chronic Obstructive Pulmonary Disease
• Primary pulmonary hypertension